Label: ALAHIST D- pheniramine maleate, phenylephrine hcl tablet
- NDC Code(s): 50991-776-01, 50991-776-02
- Packager: Poly Pharmaceuticals, Inc.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated December 6, 2022
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- ACTIVE INGREDIENT
Do not exceed recommended dosage.
Do not use this product
if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or
emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Ask a doctor before use ifyou have
- a breathing problem such as emphysema or chronic bronchitis
- trouble urinating due to enlargement of the prostate gland
- heart disease
- high blood pressure
- thyroid disease
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.
When using this product
- excitability may occur, especially in children
- may cause drowsiness
- avoid alcoholic drinks
- alcohol, sedatives, and tranquilizers may increase the drowsiness effect
- use caution when driving a motor vehicle or operating machinery
Stop use and ask a doctor if
nervousness, dizziness, or sleeplessness occur
symptoms do not improve within 7 days or are accompanied by fever
If pregnant or breast-feeding, ask a health
professional before use.
- INACTIVE INGREDIENTS
- OTHER INFORMATION
- KEEP OUT OF REACH OF CHILDREN
- Package Label
INGREDIENTS AND APPEARANCE
pheniramine maleate, phenylephrine hcl tablet
Product Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:50991-776 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength PHENIRAMINE MALEATE (UNII: NYW905655B) (PHENIRAMINE - UNII:134FM9ZZ6M) PHENIRAMINE MALEATE 17.5 mg PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV) PHENYLEPHRINE HYDROCHLORIDE 10 mg Inactive Ingredients Ingredient Name Strength SODIUM STARCH GLYCOLATE TYPE A CORN (UNII: AG9B65PV6B) MAGNESIUM STEARATE (UNII: 70097M6I30) MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) Product Characteristics Color yellow Score 2 pieces Shape OVAL Size 11mm Flavor Imprint Code A;D Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:50991-776-01 100 in 1 BOTTLE; Type 0: Not a Combination Product 04/01/2020 2 NDC:50991-776-02 12 in 1 BLISTER PACK; Type 0: Not a Combination Product 04/01/2020 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part341 04/01/2020 Labeler - Poly Pharmaceuticals, Inc. (198449894)